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Abstract
Background: Bluetongue virus (BTV) protein, VP1, is known to possess an intrinsic polymerase function, unlike rotavirus VP1,
which requires the capsid protein VP2 for its catalytic activity. However, compared with the polymerases of other members
of the Reoviridae family, BTV VP1 has not been characterized in detail.
Methods and Findings: Using an in vitro polymerase assay system, we demonstrated that BTV VP1 could synthesize the ten
dsRNAs simultaneously from BTV core-derived ssRNA templates in a single in vitro reaction as well as genomic dsRNA
segments from rotavirus core-derived ssRNA templates that possess no sequence similarity with BTV. In contrast, dsRNAs
were not synthesized from non-viral ssRNA templates by VP1, unless they were fused with specific BTV sequences. Further,
we showed that synthesis of dsRNAs from capped ssRNA templates was significantly higher than that from uncapped ssRNA
templates and the addition of dinucleotides enhanced activity as long as the last base of the dinucleotide complemented
the 39 -terminal nucleotide of the ssRNA template.
Conclusions: We showed that the polymerase activity was stimulated by two different factors: cap structure, likely due to
allosteric effect, and dinucleotides due to priming. Our results also suggested the possible presence of cis-acting elements
shared by ssRNAs in the members of family Reoviridae.
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Introduction
Viral RNA-dependent RNA polymerases (RdRps) share a
similar catalytic mechanism as well as a similar structure, including
conserved sequence motifs and catalytic residues [1,2,3,4,5].
Despite these similarities, each RdRp has different ways to
recognize RNA templates, initiate RNA synthesis, elongate the
RNA chains and regulate those activities [6,7,8,9]. For segmented,
double-strand RNA (dsRNA) viruses, including Reoviridae family
members, RNA synthesis by RdRp occurs within a capsid and is
capable of reading both single- and double-strand RNAs in
association with other inner viral proteins (polymerase complex) in
the absence of host factors [2,10,11,12,13,14,15,16,17]. It is
believed that this specific feature of dsRNA viruses allows their
RdRps to synthesize ssRNA transcripts (mRNAs) from viral
genomic dsRNA segments and viral genomic dsRNAs from
ssRNA transcripts without exposing their genomic dsRNA to the
host innate immunity sensors [18]. Recently, it was reported that
dsRNAs which were detected outside the rotavirus viroplasm
seemed to activate PKR [19].
Bluetongue virus (BTV), the etiological agent of Bluetongue
disease of livestock, is a member of the Orbivirus genus of the
family Reoviridae. BTV particles have three consecutive layers of
proteins organized into two capsids, an outer capsid of two
proteins (VP2 and VP5) and an inner capsid or ‘‘core’’ composed
of two major proteins, VP7 and VP3 which encloses the three
minor proteins VP1, VP4 and VP6 in addition to the viral
genome. The viral genome is segmented and consists of ten linear
dsRNA molecules, classified from segment 1 to segment 10 in
decreasing order of size (S1-S10) [20,21]. After cell entry, the outer
capsid is removed to release a transcriptionally active core particle,
which provides a compartment within which the ten genome
segments can be repeatedly transcribed by core-associated
enzymes including VP1, VP4 and VP6 [14,15]. Ten mRNAs
are synthesized from the ten genome segments and released from
the core particle into the host cell cytoplasm where they act as
templates both for translation and for negative strand viral RNA
synthesis to generate genomic dsRNAs [14,22]. Previously, we
demonstrated that purified BTV VP1 is active as replicase
synthesizing dsRNA from positive strand ssRNA in vitro in the
absence of any other viral protein [23,24]. However, the catalytic
activity of VP1 was not further characterized.
The crystal structures of RdRp proteins have been reported for
two members of the family, l3 of reovirus and VP1 of rotavirus
[3,4]. Both RdRp showed a similar cage-like structure with four
well-defined tunnels that allow access of the template RNAs,
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nucleotides and divalent cations to the internal catalytic site, as
well as two distinct exit channels for template RNA and products
[25]. Although the crystal structure of BTV VP1 is not known, a
secondary structure-based three-dimensional model of BTV VP1
revealed structural similarity to other Reoviridae polymerases [26].
Despite this structural similarity, BTV VP1 exhibits two distinct
functional features which distinguish it from rotavirus VP1 [24].
Firstly, BTV VP1 exhibits RNA replicase activity in the absence of
all other virus encoded proteins, whereas rotavirus VP1 requires
VP2, which forms the inner layer of the virus particle, for its
activity [27,28,29]. Secondly, our initial study indicated that BTV
VP1 does not require the 39 conserved region for in vitro dsRNA
synthesis, unlike rotavirus VP1, which recognizes the UGUG
tetranucleotide of the 39 end conserved sequence [4,24,29,30,
31,32,33]. Nevertheless, during virus replication all three proteins,
BTV VP1, reovirus l3 and rotavirus VP1, as well as dsRNA
bacteriophage phi 6 RdRp, essentially perform the same function
[3,5,24,34,35,36,37].
The crystal structure of the reovirus l3 and rotavirus VP1 also
showed that there are ‘cap’ binding sites on the surface of the cage-
like structure [3,4], suggesting that the cap appears to be the
primary element by which VP1 docks and recognizes the 59 end of
a plus strand [4,25]. The activity of influenza virus-associated
polymerase, which is well known to have a cap-snatching
mechanism, can be stimulated by cap-1 structures (m7GpppNm)
as well as dinucleotides, such as ApG and GpG [38,39,40,
41,42,43,44,45]. The regulation of transcription by cap structures
was also reported in Bunyaviridae [46]. Unlike dinucleotides, the
cap-1 structure functions as an allosteric regulatory factor, rather
than by priming transcription, with enhanced RNA synthesis by
influenza virus-associated polymerase [40,43,44,45]. Furthermore,
the cell-free system for rotavirus RNA polymerase revealed the
specific priming of minus strand RNA synthesis by a dinucleotide
rather than dinucleoside monophosphate [32], and formation of
the initiation complex with dinucleotide and template, unlike the
RdRp of dsRNA bacteriophage, phi6, which does not require a
primer for initiating dsRNA synthesis but has a ‘‘back-priming’’
initiation mechanism [47,48]. These previous studies strongly
suggest that the cap structure or dinucleotide may have an effect
on the polymerase activity of BTV VP1.
In this study, we investigated the factors that affect BTV VP1 in
vitro catalytic activity including the requirement of RNA sequences
that are recognized by BTV VP1, priming and other co-regulating
factors. We first confirmed the robustness of polymerase activity by
demonstrating that VP1 could synthesize all ten dsRNA segments
from ten individual ssRNA segments in a single reaction. Further,
we showed that in vitro polymerase activity of VP1 is sequence-
independent and could synthesize genomic dsRNAs of the other
orbiviruses or rotaviruses when provided with ssRNA templates of
these heterologous viruses. In contrast, dsRNAs were not
synthesized from non-viral ssRNA templates by VP1, unless those
were fused with some specific BTV sequences, indicating the
presence of cis-acting elements shared by members of the family
Reoviridae. Moreover, our data showed that the activity was
enhanced both in the presence of a cap structure or a dinucleotide;
although their roles appear to be distinct, one appears to be
allosteric while the other is required for priming.
Results
Polymerase activity of BTV VP1 is highly efficient in vitro
BTV VP1 has already been reported to have the ability to
synthesize dsRNA from BTV T7 ssRNA templates [24]. However,
it has not been previously shown that polymerase proteins of any
members of the family Reoviridae can synthesize the complete set of
genomic dsRNA in vitro in a single reaction mixture. Since purified
BTV VP1 alone could synthesize a duplex on a single ssRNA
template, we attempted to assess if VP1 could synthesize all ten
dsRNAs of BTV in a single reaction. Either 1.0 mg of the complete
set of in vitro synthesized ssRNAs from viral cores (core ssRNAs) or
in vitro generated ten ssRNAs from T7 plasmids (T7 ssRNAs)
[49,50], each approximately 0.1 mg, were used as templates
together with approximately 70 ng of purified VP1, significantly
less VP1 than was used previously [24], for in vitro polymerase
assay. Both reactions were carried out at 37uC for 5 h and
dsRNAs were purified from the reaction mixtures. The dsRNA
profiles of each reaction, analyzed by 7% native PAGE gel,
demonstrated clearly that purified VP1 synthesizes all ten dsRNAs
in a single reaction mixture and could utilize efficiently both
authentic core ssRNAs and the T7 ssRNAs (Fig. 1). The amount of
each synthesized segment was not equal. However, when each
single T7 ssRNA template was used for separate reactions, the
dsRNA from each T7 ssRNA was synthesized equally well (data
not shown) [24].
The data also showed that BTV VP1 could efficiently synthesize
all ten dsRNAs in the absence of any other protein, whereas
rotavirus VP1 required VP2 for single dsRNA synthesis,
suggesting that the recombinant BTV VP1 possesses robust
polymerase activity in vitro.
BTV polymerase is capable of synthesizing genomic RNAs
of rotavirus and other members of family Reoviridae
The data above confirms that BTV VP1 is not only functional
on its own and requires no other viral protein but that the activity
is also highly efficient in vitro. Thus, it is possible that VP1 may be
capable of using other related viral ssRNAs as templates. We
selected another member of the Orbivirus genus, African Horse
Sickness virus, AHSV, the genomic RNA segments of which have
Figure 1. Efficient polymerase activity of BTV VP1 in vitro. BTV
core-derived ssRNAs (lane 2), single S8 T7 ssRNA (lane 3) and all ten
segments T7 ssRNAs (lane 4) were used for the in vitro polymerase assay
as described in Materials and Methods and synthesized dsRNA were
analyzed by PAGE. The radiolabeled dsRNAs were detected by
autoradiography using Storage Phospher screen and image analyzer,
Typhoon Trio. The end-labeled BTV1 genome segments were used as
markers (lane 1). Genome segments are indicated.
doi:10.1371/journal.pone.0027702.g001
BTV Polymerase
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59 and 39 conserved regions similar to those of BTV genomes
(Fig. 2A). For this study, we used the complete set of ssRNAs of
AHSV-4, synthesized in vitro from purified cores, the completeness
of which were confirmed by reverse genetics [51]. In parallel, we
also used several T7 ssRNAs (S4, S5 and S10) of AHSV-4 as
templates for in vitro polymerase assay. Polymerase reactions were
carried out with either the core ssRNA templates or the single T7
ssRNA templates as described above. When purified dsRNAs were
analyzed by 7% native-PAGE gel, dsRNA segments were
detectable from each template (Fig. 2B).
To investigate further if VP1 could synthesize dsRNA on an
ssRNA template of another member of the family, we selected
rotavirus ssRNA templates derived from rotavirus double-layered
particles (DLPs), which are equivalent to BTV cores, in vitro.
Rotavirus DLP ssRNAs (11 segments) were generated in vitro from
purified DLPs of SA11, a strain of simian rotavirus, and again
used as templates as described. Surprisingly, although genome
sequences of rotaviruses are different from those of BTV
serotypes (Fig. 2A), BTV VP1 could indeed synthesize dsRNAs
from each rotavirus DLP ssRNAs (Fig. 2C). Similar results were
obtained when rhesus rotavirus DLP ssRNAs or bovine rotavirus
DLP ssRNAs were used as templates (data not shown). These
results confirmed that the in vitro polymerase activity of BTV VP1
is sequence-independent at least within the family Reoviridae.
Alternatively, viruses belonging to the family Reoviridae may share
some motif or elements in their genomic RNAs, which may be
required for polymerase activity. To verify this further, three non-
viral ssRNAs, a luciferase gene ssRNA (,1800 nucleotides), a
puromycin resistant gene ssRNA (PAC, 609 nucleotides) and an
EGFP gene ssRNA (729 nucleotides) (Fig. 3B) were used as
templates. In addition, one chimeric S9-EGFP gene (S9E 277/
657) (Fig. 3A and B), which was established previously as a
functional segment in vivo [50], was also used as a template. None
of the non-viral ssRNAs could serve as templates to generate
correct duplexes (Fig. 3C, lanes 2–4). However, when the
chimeric S9-EGFP gene, in which BTV RNA sequences were
fused with EGFP RNA, was used as a template, a ‘‘perfect’’
chimeric dsRNA was synthesized similar to the wild-type S9
(Fig. 3C, lanes 5 and 6). These data suggested that some
sequence-based character of BTV segments, such as certain
secondary structure of ssRNA, is necessary for polymerase
activity of BTV. It is possible that other members of the family
may also possess similar characteristics.
Does Cap structure of ssRNA stimulate polymerase
activity?
It is known that a 59 cap structure can regulate viral polymerase
activity as well as stabilize ssRNA [40,43,44,45,46]. Additionally,
the crystal structure of reovirus l3 and rotavirus VP1 revealed that
it has cap-binding sites on the surface of its cage-like structure,
close to the entry channel for template ssRNA [3,4]. Similarly, the
study on rotavirus polymerase VP1 suggests that the cap appears
to be the primary element by which VP1 docks and recognizes the
59 end of a plus strand RNA [4]. Previous work has shown that
T7-derived uncapped BTV ssRNAs could serve as templates for in
vitro polymerase reactions but a role for the cap structure as an
enhancing element was not investigated [24]. Since the positive-
sense RNAs of the BTV genome possess a cap structure at the 59
end, we assessed the role of the cap structure on the polymerase
activity of BTV VP1. Thus, the efficiency of dsRNA synthesis was
compared between capped T7 S9 ssRNA and uncapped T7 S9
ssRNA templates. Several serial dilutions (2-fold and 3-fold) of
both types of templates were used for polymerase assay and the
final dsRNA products were analyzed by native PAGE gel as
described above (Fig. 4, upper panel). The radioactivity of each
dsRNA band was quantified by using ImageJ software as described
in Materials and Methods (Fig. 4, lower panel). The yield of
dsRNAs from capped T7 S9 ssRNAs was higher than that from
uncapped T7 S9 ssRNAs (Fig. 4). No significant difference was
observed between the Km value of capped T7 S9 ssRNA and that
of uncapped T7 S9 ssRNA (6.7861.674 vs 5.7563.287, P.0.05),
suggesting that the presence of cap structure at 59 end did not
affect on the affinity of ssRNA template to VP1. However, the
Vmax value of capped T7 S9 ssRNA was approximately six fold
higher than that of uncapped T7 S9 ssRNA (64.3765.88 vs
11.6262.254, P,0.01), suggesting that the presence of cap
Figure 2. Sequence-independent polymerase activity of BTV VP1. A. Schematic representation of conserved regions at both 59 and 39 end of
rotavirus, AHSV and BTV. B. AHSV-4 core-derived ssRNAs (lane 2) and AHSV-4 T7 ssRNAs (S10, lane 3; S5, lane 4; S4, lane 5) were used as templates.
The radiolabeled dsRNAs were detected by autoradiography. The end-labeled genome segments were used as markers (lane 1). Arrows indicate
synthesized dsRNA. Note that AHSV4 S6 migrates slower than AHSV4 S5. C. Simian rotavirus (SA11) DLP ssRNAs (lane 2) were used as templates. The
end-labeled genome segments of simian rotavirus (SA11) were used as markers (lane 1). Genome segments are indicated.
doi:10.1371/journal.pone.0027702.g002
BTV Polymerase
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structure at 59 end of ssRNA template increased VP1 catalytic
activity. Moreover, dsRNA synthesis was saturated by approxi-
mately 0.5 mg of input ssRNA template, regardless of being
capped or not. In addition, although the amount of ssRNA
decreased after 5 h of reaction, uncapped ssRNA still remained
intact after the reaction (data not shown). These results suggested
that the lower efficiency of dsRNA synthesis from uncapped
ssRNAs was not due to template instability. These results support a
model in which the cap structure of the template influences the
catalytic activity of BTV VP1.
Our previous study using a two-transfection reverse genetics
(RG) system had suggested that the cap structure was not
essential for genome packaging in BTV [50]. To further confirm
the role of cap structure in BTV replication, we repeated the
two-transfection RG schedule using for the first transfection
only the genes that are essential for synthesis of the protein
components of the primary replicase complex (S1, S3, S4, S6,
S8, and S9) [50]. In the second transfection, the complete set of
10 ssRNA, all uncapped, were included as described in
Materials and Methods. The lack of the capped RNA in all
ten segments in the second transfection, which provides the
BTV genome templates, reduced the efficiency of virus recovery
(Fig. 5, column 2). However, lack of a cap structure on only the
T7 S9 ssRNA did not reduce virus recovery (Fig. 5 column 3). It
is noteworthy that the amount of VP4 synthesised by the first
transfection of S4 into BSR cells was negligible and was
incapable to form cap structure efficiently at 59 end of an
uncapped ssRNA [50]. These results indicated that, in addition
to the initiation of translation and stabilization of mRNAs
transcribed from core particles, there might be a role for cap
structures for the enhancement of VP1 activity during assembly
of the primary replication complex.
Stimulation of polymerase activity by the 59cap structure
of template ssRNA is not due to priming or initial
recognition of template but likely due to an allosteric
modulation
To further investigate the precise role of the cap structure in
enhanced VP1 activity we made use of various cap analogues to
determine their effect on dsRNA synthesis. Several types of cap
analogue, 39-O-methyl-m7GpppG (Anti-Reverse Cap Analogue,
ARCA), m7GpppG, GpppG and GpppA were added to a
standard reaction mixture containing 0.5 mg of capped or
uncapped T7 S9 ssRNAs. Interestingly, the dsRNA synthesis
from both capped and uncapped T7 S9 ssRNA was enhanced by
the addition of all cap analogues, with GpppG showing the
greatest enhancement (Fig. 6). Together with the kinetics data
shown above, the fact that the presence of cap analogues did not
compete for VP1 activity suggests that the 59 cap structure of
template ssRNA is not the primary element by which VP1
recognizes ssRNA template but that it acts to enhance the activity.
Moreover, although there is the possibility that the enhancement
of polymerase activity is due to artificial direct priming by the cap
analogues, the fact that addition of the cap analogues enhanced
the activity, together with the in vivo data shown above, suggests
that the 59 cap structure may act to stimulate activity in trans.
T7 polymerase has a sequence preference, such as GpGpGp at
the 59 end of nucleotides [52]. To determine whether the
enhancement of polymerase activity was due to sequence
preference at the 59 end of the template ssRNA, we modified
the T7 S9 ssRNA by adding either guanosine (Gp-S9) or
adenosine (Ap-S9) at the 59 end of T7 S9 ssRNA and tested the
efficiency of the dsRNA synthesis from these templates (Fig. 7,
upper panel). In parallel, unmethylated capped T7 S9 ssRNAs
Figure 3. Requirement of cis-acting element for BTV polymerase activity. A. Schematic representation of modified S9 transcripts [50].
B. ssRNA templates were synthesized using T7 polymerase. Lane 1, ssRNA markers; lane 2, luciferase gene (about 1800 nucleotides); lane 3, PAC gene
(about 609 nucleotides); lane 4, EGFP gene (about 729 nucleotides); lane 5, chimeric S9-EGFP, EGFP277/657, (1389 nucleotides) and lane 6, wild type
BTV10 S9 (1049 nucleotides). The numbers on the left indicate the lengths of the markers in nucleotides. C. dsRNA synthesis from luciferase gene
(lane 2), PAC gene (lane 3), EGFP gene (lane 4) and chimeric S9-EGFP, EGFP277/657, ssRNA template (lane 5) was compared with wild type BTV10 S9
(lane 6). The radiolabeled bands were detected by autoradiography. The arrows indicate the bands with the correct size. The end-labeled BTV1
genome segments were used as markers (lane 1). Genome segments are indicated on the left.
doi:10.1371/journal.pone.0027702.g003
BTV Polymerase
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(Gppp-S9) and methylated capped T7 S9 ssRNAs (39-O-methyl-
m7Gppp-S9) were tested for their effects on the dsRNA synthesis
(Fig. 7, upper panel). The amount of dsRNA synthesized from
each template was compared using quantitative autoradiography
as described in Materials and Methods (Fig. 7, lower panel). The
amount of dsRNA synthesized from Gp-S9 was five times more
than that from uncapped T7 S9 ssRNA whereas the dsRNA
synthesized from Ap-S9 did not increase (Fig. 7, columns 1, 4 and
5). Additionally, the dsRNA synthesis from unmethylated or
methylated capped S9 ssRNA was higher than uncapped T7 S9
ssRNA (Fig. 7, columns 1–3). These results suggested that BTV
VP1 has a sequence preference for GpG at the 59 end, which may
mimic the authentic cap structure, GpppG.
Dinucleotides stimulate polymerase activity by priming
the initiation of dsRNA synthesis
Polymerase activities of some viruses, such as Influenza virus,
Bovine viral diarrhea virus, Hepatitis C virus and GB virus-B, are
initiated by dinucleotides due to priming the transcription
initiation [41,53,54,55]. Additionally, the study using rotavirus
open cores showed that GpG, which complements the sequences
of the 39 end of rotavirus G8 ‘plus’ strand RNA, forms initiation
complexes with VP1 and template ssRNA to initiate ‘minus’ strand
Figure 4. Comparison of the dsRNA synthesis between capped
and uncapped T7 S9 ssRNA. Serial diluted (2-fold and 3-fold) capped
or uncapped T7 S9 ssRNAs were added to the reaction mixture
containing 70 mg of VP1 (upper panel). Several serial dilutions of
capped (circle) or uncapped (square) T7 S9 ssRNAs were performed. The
radiolabeled bands were detected by autoradiography. The intensity of
each band was quantified using ImageJ software (NIH: http://rsb.info.
nih.gov/ij/) and plotted on the graph (lower panel). The fitted curves
shown on the graph were calculated using the program Prism
(GraphPad Software, USA). The kinetics parameters were determined
by the Michaelis-Menten equation as described in Materials and
Methods and shown on the graph.
doi:10.1371/journal.pone.0027702.g004
Figure 5. Recovery of BTV from uncapped ssRNA. The recovery of
BTV from RNA generated in vitro was compared using uncapped and
capped ssRNA in the second transfection. BSR cells were transfected
first with 6 capped ssRNAs (S1, S3, S4, S6, S8 & S9) and subsequently
with all capped ssRNAs (column 1), all uncapped ssRNAs (column 2) or
uncapped S9 together with remaining 9 capped ssRNAs (column 3).
Each ssRNA was at 50 ng per transfection. The recovery of virus was
shown as the total number of plaques per well (Mean 6 SD).
doi:10.1371/journal.pone.0027702.g005
Figure 6. The effect of cap analogues on BTV polymerase
activity. Each 20 pmol of cap analogues indicated at the bottom of
each column, was added to the reaction mixture with 0.5 mg of
uncapped (upper panel) or capped (lower panel) T7 S9 ssRNA and
70 mg of VP1. The radioactive intensity of each sample was standardized
by control sample (ctrl), which was added water instead of cap
analogue. The efficiency of dsRNA synthesis of each sample was shown
as a fold of control (Mean 6 SD). Asterisks are showing significant
difference (**P,0.01; *P,0.05).
doi:10.1371/journal.pone.0027702.g006
BTV Polymerase
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synthesis [32]. To determine the effect of dinucleotide on the BTV
polymerase activity, several types of dinucleotides were added to
the polymerase reaction mixture. Three dinucleotides, GpG, GpA
and ApG, which consisted of the same nucleotides as cap
analogues, were tested with 0.5 mg of T7 S9 ssRNA. When the
products were analysed the data showed clearly that GpG and
ApG, which complement only the last nucleotide of the 39 end
sequence of BTV S9 plus strand RNA, strongly enhanced the
polymerase activity (Fig. 8, columns 2 and 4). Similarly, biotinated
pApG (biotin-ApG), which was incorporated only once at the 59-
end, also showed the strong enhancement of polymerase activity
(Fig. 9A). In contrast, GpA did not enhance the observed activity
(Fig. 8, column 3). Subsequently four more dinucleotides, GpU,
GpC, CpU and UpA were tested for their effects on dsRNA
synthesis. Of these, only GpU, which complements the last two
bases of the 39 end sequence of BTV S9 plus strand RNA, strongly
enhanced the dsRNA synthesis whereas GpC, CpU and UpA,
which fail to complement the 39 end sequence of BTV S9 plus
strand, did not exhibit any detectable enhancement (Fig. 8,
columns 5–7). These results suggest that dinucleotides are capable
of stimulating BTV polymerase activity by priming the initiation of
dsRNA synthesis, similar to that observed for rotavirus VP1 [32].
To confirm this further, biotin-ApG was used for the non-
radioactive polymerase assay as described in Materials and
Methods. When biotin-ApG was added to the reaction mixture
containing non-radiolabeled rNTPs, the newly synthesized
dsRNAs were labeled with biotin at the 59 end of the negative
sense RNA and detected at the same position as S9 viral dsRNA
stained with methylene blue (Fig. 9B). Interestingly, GpG always
enhanced polymerase activity more than ApG. Additionally, the
amount of dsRNA synthesized from Gp-S9 was at least five times
more than that of uncapped T7 S9 ssRNA whereas synthesis of
dsRNA from Ap-S9 did not increase (Fig. 7). Thus, while ApG
could stimulate activity by priming, albeit less efficiently than
GpU, GpG was superior, plausibly as a result of direct priming
and allosteric stimulation, as it may mimic the effect of GpppG.
Discussion
We previously demonstrated that BTV VP1 could act as a
replicase in the absence of any other virus or host protein [23,24],
in contrast to rotavirus VP1, which failed to exhibit catalytic
activity in the absence of the inner capsid protein VP2 [29]. In this
study, we further confirmed the robustness and versatility of the
BTV VP1 replicase activity by demonstrating that it could
synthesize all ten dsRNAs simultaneously from BTV core-derived
ssRNA templates in a single in vitro reaction in the absence of any
other virus proteins. In addition, genomic dsRNA segments from
rotavirus DLP-derived ssRNA templates that possess no sequence
similarity with BTV also acted as templates, suggesting that this
assay system could be an advantage for the future studies of
Reoviridae RdRp.
Figure 7. The effect of 59 sequence of ssRNA template on BTV
polymerase activity. Each 0.5 mg of uncapped (Uncapped, column 1),
anti-reverse capped (ARCA, column 2), non-methylated capped (GpppG,
column 3) or 59 extended T7 S9 ssRNAs (GpG, column 4; ApG, column 5)
was added to the reaction mixture. Schematic representation of each
59-modified T7 S9 ssRNA was shown on the upper panel. The
radioactive intensity of each sample was standardized by uncapped
T7 S9 ssRNA sample (lower panel). The efficiency of dsRNA synthesis of
each sample was shown as a fold of uncapped T7 S9 ssRNA sample
(Mean 6 SD). The radiolabeled bands were detected by autoradiog-
raphy. The intensity of each band was counted using ImageJ software.
Asterisks are showing significant difference (**P,0.01; *P,0.05).
doi:10.1371/journal.pone.0027702.g007
Figure 8. The effect of dinucleotides on BTV polymerase
activity. Each 20 pmol of dinucleotide indicated at the bottom of each
column was added to the reaction mixture containing 0.5 mg of either
uncapped (upper panel) or capped (lower panel) T7 S9 ssRNA template.
The radioactive intensity of each sample was standardized by control
sample (ctrl, column 1), which was added water instead of dinucleotide.
The efficiency of dsRNA synthesis of each sample was shown as a fold of
control (Mean 6 SD). Asterisks show significant difference (**P,0.01;
*P,0.05).
doi:10.1371/journal.pone.0027702.g008
BTV Polymerase
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The 39 conserved sequence in rotavirus RNA segments is
essential for polymerase activity [4,29,30,32,33]. In addition,
although the initiation mechanism differs from the family
Reoviridae, the 39 end sequence is important for the pre-initiation
events of bacteriophage phi6 RdRp, which assembles into a
productive binary complex with template ssRNA [56]. However,
in our preliminary study BTV VP1 did not require conserved
termini for its catalytic activity, suggesting that BTV VP1 has
sequence-independent replicase activity [24]. In the present study,
we confirmed its sequence-independent activity by demonstrating
that BTV VP1 could synthesize correct dsRNA segments from
viral genomic templates of other Reoviridae. AHSV has 59 and 39
conserved regions in its genome similar to BTV genomic RNA
whereas rotavirus genomes, especially the terminal conserved
regions, are very different from BTV. Nonetheless, BTV VP1
could synthesize dsRNAs of rotavirus with correct sizes, suggesting
strongly that BTV polymerase activity was sequence-independent
in vitro. The amount of each synthesized segment was not equal.
This phenomenon was also observed in rotavirus open core system
[57]. There may be some structural constraints in certain ssRNAs.
However, the dsRNA was well synthesized from single T7 ssRNA
template of AHSV S4 unlike the AHSV core ssRNA template.
Although further investigations are required, it may be that a
mixture of several ssRNA segments in a single reaction may cause
RNA-RNA interaction, thereby preventing the 39 end of some
ssRNA from reaching at the active site of VP1 and consequently
resulting in uneven dsRNA synthesis. When non-viral ssRNAs
were used as templates, BTV VP1 failed to synthesize dsRNAs of
correct lane sizes. Smearing and many truncated bands were
detected, suggesting premature termination as well as poor
template recognition. This phenomenon is not due to the lack of
cytidine at the 39 end of non-vial ssRNAs as VP1 could still
synthesize dsRNA from S2 mutant, which does not possess
cystidine at 39 end [24]. Several virus polymerase activities are
already known to regulate their transcription by structure-based
cis-acting replication elements in their genomic or subgenomic
RNAs [58,59,60,61,62,63]. In rotavirus replication, the presence
of cis-acting functional elements of rotavirus ssRNAs has been
suggested [30,31,64,65,66]. We previously demonstrated the
presence of cis-acting sequences required for replication or
packaging [50]. When the functional S9-EGFP transcript,
S9E277/656, was added to the reaction, dsRNA synthesis was
efficient, as expected. A role for a conserved feature in the
templates of the family Reoviridae, required for polymerase activity,
is suggested by these results although the precise nature and
location remains to be determined.
The most important role of the 59 cap structure in eukaryotic
mRNAs is in the initiation of translation. However, it is also
known to regulate RNA synthesis in virus replication
[40,43,44,45,46]. The crystal structure of reovirus l3 and
rotavirus VP1 revealed a cap-binding site on the surface of their
cage-like structures [3,4], suggesting that the cap was the primary
element by which VP1 interacts with and recognizes the 59 end of
a positive-strand. The putative model structure of BTV VP1 has a
strong similarity with the RdRp structures of other members of the
family [26] and our data here suggest that this similarity extends to
cap recognition by, and stimulation of, replicase activity in BTV.
As demonstrated by the competition assays with various cap
analogues and kinetic analysis, this effect was not due to direct
VP1 recognition of the 59 end of the ssRNA template that is
suggested for other members of the family [3,4], but it is likely due
to an allosteric modulation. Precise kinetic support for the effect of
cap structure for RdRps activity may come from further
investigation of BTV VP1 and other members of the RdRp
family. Our data also demonstrate that the cap structure is unlikely
to play any role in genome packaging of BTV, although it could be
important for dsRNA synthesis during primary replication. The
influence of the cap structure in virus replication is worthy of
future investigation using additional reverse genetics experiments.
A dinucleotide, GpG, had been shown to be incorporated into
the 59-end of the newly synthesized negative sense RNA,
suggesting that GpG primes dsRNA synthesis by forming the
replication initiation complex with template RNA and RdRp in
the early step of rotavirus replication [32]. Our results also showed
that dinucleotides GpG, ApG and GpU could stimulate BTV VP1
replicase activity by priming although priming by either GpG or
ApG resulted in synthesis of artificial dsRNA with the 59-overhang
of negative sense RNA. This indicated that the last nucleotide, ‘G’
of the dinucleotides that complemented the 39 end of the template
sequence was sufficient to prime the activity. This feature of BTV
VP1 is not shared by rotavirus VP1 as ApG failed to prime in
rotavirus open core polymerase assay [32]. There are several
characteristics of BTV VP1 activity that are noteworthy. For
example, dsRNA synthesis from Gp-S9 ssRNA template was more
efficient than that from uncapped S9 ssRNA template and the
GpG was a better stimulator for polymerase activity than that of
ApG. This indicates that in addition to priming, GpG could
Figure 9. The priming activity of ApG. A. The effect of biotin-
labeled ApG (Bio-ApG) on BTV polymerase was compared with non-
labeled ApG (ApG). Each 20 pmol of ApG or Bio-ApG was added to the
reaction mixture containing [a-32P] CTP. B. Priming activity by
dinucleotide, ApG, was detected using biotin-labeled ApG and non-
radioactive polymerase assay as described in Materials and Methods. As
markers, BTV genomic segments was used and stained with 0.02% (w/v)
methylene blue after transferring to the nylon membrane (lane 1). Non-
labeled ApG (lane 2) or biotin-labeled ApG (lane 3) was added the
reaction mixture containing non-labeled rNTP with uncapped T7 S9
ssRNA. Biotin-labeled dsRNAs were detected using Streptavidine-
alkaline phosphatase conjugate as described in Materials and Methods.
Genome segments are indicated on the left.
doi:10.1371/journal.pone.0027702.g009
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enhance the activity by allosteric effect, possibly due to some
similarity to GpppG. Although further study is necessary to clarify
the effect of GpG and ApG, and in addition if they possess
allosteric effect, our results indicated that the replicase activity of
BTV VP1 could be stimulated by dinucleotide priming at the
initiation of replication.
In summary, in this study we showed two stimulation factors of
VP1 replicase activity, allosteric effect of cap structure and priming
effect of dinucleotides as well as the possible presence of cis-acting
element shared by ssRNAs in the members of family Reoviridae.
Our system for polymerase assay could be modified for in vitro
assembly assay of the replication complex to further clarify the
mechanism of BTV replication in the future.
Materials and Methods
Expression and Purification of his-tagged BTV VP1
The his-tagged VP1 was expressed in the Spodoptera frugiperda
(Sf9) cell line (ATCC, Rockville, MD) and purified as described
previously with some modifications [24]. Briefly, Sf 9 cells were
infected with AcBTV10.NHis1 at a multiplicity of infection of 5.0.
At 2 days post-infection, cells were harvested and lysed with VP1
lysis buffer (50 mM sodium phosphate pH8.0, 10% (v/v) glycerol,
0.5% (v/v) Nonidet P-40) containing 16protease inhibitors
(Protease Inhibitor Cocktail Set V EDTA-Free, Calbiochem).
Nuclei and cell debris were removed by centrifugation at 9400 g
for 1 hour (h) at 4uC. The cell lysate was mixed with HIS-SelectH
Nickel Affinity Gel (Sigma) for 1 h at 4uC. After washing the
affinity gel with 50 mM sodium phosphate buffer (pH 8.0)
containing 10% glycerol and 20 mM imidazole, his-tagged VP1
was eluted with 50 mM sodium phosphate buffer (pH 8.0)
containing 10% glycerol and 300 mM imidazole. The eluted
his-tagged VP1 was diluted at one in five with 50 mM Tris-HCl
buffer (pH 8.0) containing 10% glycerol and 1 mM DTT and
further purified by the affinity column, Hi-TrapH Heparin HP
column (GE Healthcare), using AKTA system (GE Healthcare)
with a linear sodium chloride gradient (100 mM-1000 mM).
Preparation of single-stranded RNA (ssRNA) for
polymerase assay and use in reverse genetics recovery
of virus
Single-stranded RNAs (ssRNA) of BTV, African horse sickness
virus (AHSV), simian rotavirus, rhesus rotavirus and bovine
rotavirus were synthesized in vitro using purified core particles or
double-layered particles of each virus (core ssRNA or DLP ssRNA)
as described previously [51,67,68,69]. For synthesis of ssRNA with
T7 RNA polymerase (T7 ssRNA), T7 plasmids constructed
previously [49,50] were used. All BTV genome sequences were
deposited in GenBank (Accession numbers: FJ969719, FJ969720,
FJ969721, FJ969722, FJ969723, FJ969724, FJ969725, FJ969726,
NC006008, NC006015, FJ969727 and FJ969728). For synthesis of
59 extended S9 ssRNAs, EGFP ssRNA and puromycin N-
acethyltransferase (PAC, puromycin resistant gene) ssRNA, PCR
products were used as templates. The following primers were used
for the PCR amplification: T7EGFP-F (59- taatacgactcactatagg-
gATGGTGAGCAAGGGCGAGGA), T7PUR-F (taatacgactcac-
tatagggATGACCGAGTACAAGCCCAC), T7GS9-F (59-taatac-
gactcactataGGTTAAAAAATCGCATATGTC), T7AS9-F (59-
taatacgactcactataAGTTAAAAAATCGCATATGTC), EGFP-R
(59-tttccatggTTACTTGTACAGCTCGTCCA), PUR-R (59-ctaa-
gatctTCAGGCACCGGGCTTGCGGG) and S9-R (59- GTA-
AGTGTGAAATCGCCCTACGTCA). For synthesis of luciferase
ssRNA, control linear DNA from RiboMAX Large Scale RNA
Production System-T7 kit (Promega) was used. Capped T7
ssRNAs were synthesized using mMESSAGE mMACHINE T7
Ultra Kit (Ambion) according to manufacturer’s protocols. For
synthesis of uncapped T7 ssRNAs and unmethylated capped T7
ssRNA, RiboMAX Large Scale RNA Production System-T7
(Promega) was used according to the manufacturer’s procedures.
The unincorporated nucleotides and cap analogues were removed
using Illustra MicroSpin G25 columns (GE Healthcare) during
standard phenol/chloroform purification methods. The synthesized
ssRNAs were dissolved in nuclease-free water, and stored at280uC.
Polymerase assay
Polymerase assay was performed as described previously with
some modifications [24]. Briefly, 70 ng of his-tagged VP1 and
several amounts of ssRNA templates were added to 50 ml of
reaction mixture (50 mM Tris-HCl pH7.4, 6 mM magnesium
acetate, 600 mM Manganese chloride, 320 mM ATP, 320 mM
GTP, 320 mM UTP, 2 mM CTP, 0.2 mCi/ml [a-32P] CTP (Perkin
Elmer), 2% (w/v) PEG4000, and 1.6 U RNasin plus (Promega) in
presence and absence of 20 pmol of cap analogues (New England
Biolabs) or 20 pmol 59-hydroxyl dinucleotides (IBA). Note that
ssRNA templates were not denatured. After incubation for 5 h at
37uC, synthesized dsRNAs were purified using a standard phenol/
chloroform method and analyzed using native-PAGE. Note that
the dsRNA synthesis in the VP1 reactions proceeded in a linear
manner for at least 5 h [24]. As markers, end-labeled- dsRNA
genomes purified from virus-infected cells were used as described
previously [24]. Gels were dried and exposed to Storage Phospher
screen (GE HEalthcare). The radiolabeled dsRNAs were detected
using the image analyzer, Typhoon Trio (GE HEalthcare), and
each radiolabeled band was quantified using ImageJ software
(NIH: http://rsb.info.nih.gov/ij/).
The experimental data was then fitted by a nonlinear regression
method using the program Prism (GraphPad Software, USA). The
kinetics parameters were determined by the Michaelis-Menten
equation:
v~Vmax S½ = Kmz S½ ð Þ
where [S] is the substrate concentration (ng/ml); Km is the apparent
Michaelis-Menten constant; and Vmax is the maximal rate attained
when the enzyme active sites are saturated by substrate (quantified
radioactive count/min).
Transfection of cells with BTV transcripts
BSR monolayers in twelve-well plates were transfected twice
with BTV mRNAs using Lipofectamin 2000 Reagent (Invitrogen)
as describe previously [50]. BTV transcripts were mixed in Opti-
MEM (Invitrogen) containing 0.5 U/ml of RNasin plus (Promega)
before being mixed with Lipofectamin 2000 Reagent in Opti-
MEM containing 0.5 U/ml of RNasin plus. The transfection
mixture was incubated at 20uC for 20 min and then added directly
to cells. The first transfection was performed with a standard of
50 ng of each T7 transcript (S1, S3, S4, S6, S8 and S9), and a
second transfection, again with 50 ng of each of the ten T7
transcripts, at 18 h post first transfection. At 6 h post second
transfection, the culture medium was replaced with 1.5 ml overlay
consisting of DMEM, 2% FBS, and 1.5% (wt/vol) agarose type
VII (Sigma) and the plates were incubated at 35uC in 5% CO2 for
3 days to allow plaques to appear.
Priming assay
A modified method of polymerase assay was used for measuring
dinucleotide priming. Briefly, 70 ng of His-tagged VP1 and 0.5 mg
BTV Polymerase
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of T7 S9 ssRNA were added to 50 ml of reaction mixture (50 mM
Tris-HCl pH7.4, 6 mM magnesium acetate, 600 mM Manganese
chloride, 320 mM ATP, 320 mM GTP, 320 mM UTP, 320 mM
CTP, 2% (w/v) PEG4000, and 1.6 U RNasin plus (Promega)) in
presence of 20 pmol of biotin-labeled ApG (IBA). After separation
by native-PAGE gel, samples were transferred to the positive-
charged nylon membrane, Hybond N+ (GE Healthcare) and
Biotin-labeled dsRNA bands were detected using Streptavidine-
alkaline phosphatase conjugate (Sigma) and BCIPH/NBT Alkaline
Phosphatase Substrate (Sigma) by the same method as with the
Biotin Luminescent Detection Kit (Roche Applied Science). As
markers, purified dsRNA genomes were used and stained with
methylene blue solution (0.02% (w/v) methylene blue, 0.3 M
sodium acetate, pH 5.0) after transferring to the nylon membrane.
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